Home / Health / Miracle Gene Therapy Saves Young Alaskan Boy
Miracle Gene Therapy Saves Young Alaskan Boy
31 Jul
Summary
- Youngest MLD patient receives gene therapy at Children's Hospital of Philadelphia.
- Early diagnosis via newborn screening is crucial for successful gene therapy.
- Nicholas, a baby from Alaska, is now thriving after treatment.
A young child from Alaska, identified as Nicholas, recently underwent gene therapy at the Children's Hospital of Philadelphia (CHOP), becoming the youngest patient to receive treatment for metachromatic leukodystrophy (MLD). MLD is a fatal genetic disease that affects infants, causing them to lose motor functions.
The success of this groundbreaking treatment hinges on early detection, ideally through newborn screening tests. Nicholas's family traveled from a remote Alaskan village to Philadelphia to secure this chance for him.
Tragically, Nicholas's older sister, Emily, who also had MLD, passed away because her treatment began too late. Their mother has now lost two older children to the disease.
Nicholas's gene therapy involved removing his bone marrow stem cells, followed by chemotherapy to prepare for the infusion of modified genes. This treatment has shown remarkable success, with Nicholas now walking and talking.
CHOP is aiming to extend this life-saving therapy to more children, but broader implementation depends on more states adding MLD to standard newborn screening. Currently, only a few states, including New York and Pennsylvania, offer this screening. Nicholas has returned to Alaska and is reportedly doing well, with CHOP having treated seven other children with MLD since his case.
